查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1551731

糖尿病眼科疾病设备的全球市场

Diabetic Eye Disease Devices
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 270 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球糖尿病眼科疾病设备市场将达到 16 亿美元

全球糖尿病眼科疾病设备市场预计到 2023 年将达到 10 亿美元，预计到 2030 年将达到 16 亿美元，2023-2030 年分析期间复合年增长率为 6.2%。玻璃体手术是本报告分析的细分市场之一，预计复合年增长率为 6.4%，到分析期结束时将达到 12 亿美元。在分析期间，雷射手术领域的复合年增长率预计为 5.7%。

美国市场预估为2.795亿美元，中国预期复合年增长率为10.1%

预计2023年美国糖尿病眼科疾病设备市场规模将达2.795亿美元。中国作为全球第二大经济体，预计2030年市场规模将达3.375亿美元，2023-2030年复合年增长率为10.1%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 2.6% 和 6.3%。在欧洲，德国的复合年增长率预计为 3.9%。

全球糖尿病眼科疾病设备市场－主要趋势与驱动因素总结

什么是糖尿病眼科疾病设备？

糖尿病眼科疾病设备是一种专门的医疗工具和技术，旨在诊断、监测和治疗与糖尿病相关的眼部疾病，如糖尿病视网膜病变、糖尿病黄斑部水肿、白内障和青光眼。如果不及时发现和治疗，这些疾病可能导致严重的视力损害和失明。糖尿病眼科疾病设备在这些疾病的早期检测和持续管理中发挥重要作用，鑑于糖尿病眼科疾病的进行性，这一点至关重要。鑑于糖尿病眼科疾病的进行性，糖尿病眼科疾病设备极为重要。这些设备的重要性在于它们能够识别视网膜损伤的早期迹象，例如微动脉瘤和出血，而患者在视力显着下降之前可能不会注意到这些迹象。透过及时干预，这些设备可以帮助预防或减缓糖尿病眼科疾病的进展，从而保护视力并改善患者的生活品质。随着全球糖尿病盛行率持续上升，在对抗糖尿病相关视力丧失方面，对有效、可靠的糖尿病眼科疾病设备的需求比以往任何时候都更加重要。

科技进步如何增强糖尿病眼科疾病设备？

技术进步显着提高了糖尿病眼科疾病设备的有效性、准确性和可近性。光同调断层扫瞄(OCT) 和眼底摄影等现代诊断工具可提供高解析度的视网膜影像，从而可以详细检查眼睛的内部结构。这些技术使临床医生能够识别出显示疾病进展的视网膜细微变化，从而彻底改变了糖尿病视网膜病变和黄斑部水肿的早期检测。此外，将人工智慧（AI）和机器学习演算法整合到这些设备中进一步提高了诊断准确性和效率。人工智慧驱动的视网膜筛检工具可以高精度地分析影像，寻找糖尿病眼科疾病的征兆，通常可以匹配甚至超过人类专家的表现。这项技术在眼科医生有限的偏远和服务欠缺地区尤其有价值。此外，雷射治疗设备的进步，例如用于全视网膜光凝固和聚焦雷射治疗的设备，正在提高治疗性介入的准确性和安全性，降低併发症的风险，并改善患者的治疗效果。这些技术改进不仅使糖尿病眼科疾病设备更有效，而且提高了其可用性和易用性，使更多患者得到及时、适当的治疗。

为什么患者和医疗保健提供者接受糖尿病眼科疾病设备？

由于迫切需要管理日益增加的糖尿病相关眼科疾病负担，患者和医疗保健提供者越来越多地采用糖尿病眼科疾病设备。对于患者来说，这些设备提供了一种积极主动的眼睛健康方法，可以定期监测并及早发现潜在问题，避免导致视力严重丧失。此外，视网膜成像和 OCT 扫描等非侵入性诊断测试的便利性使患者更容易接受定期检查，而不会感到不适或冗长的程序。此外，随着人们对糖尿病眼科疾病相关风险的认识不断提高，以及先进筛检技术的出现，越来越多的患者接受定期眼科检查，作为糖尿病管理计画的一部分。对于医疗保健提供者而言，糖尿病眼科疾病设备提供了一种可靠且有效的方法来诊断糖尿病患者的眼睛状况并追踪其进展。儘早检测视网膜的细微变化的能力可以及时进行干预，以防止严重併发症并最终改善患者的治疗结果。此外，将人工智慧和远端医疗解决方案整合到这些设备中将扩大获得专业护理的机会，特别是在眼科服务较差的地区，使这些设备成为现代糖尿病管理的重要工具。

推动糖尿病眼科疾病设备市场成长的因素有哪些？

糖尿病眼科疾病设备市场的成长是由几个关键因素推动的，这些因素反映了全球糖尿病盛行率的不断上升以及併发症进行有效管理的需要。主要因素之一是全世界糖尿病盛行率不断上升，特别是在高龄化社会以及肥胖率和久坐生活方式高的地区。随着越来越多的人被诊断出患有糖尿病，对能够监测和治疗相关眼部疾病的设备的需求正在迅速增加。高解析度成像系统的开发、人工智慧诊断工具和更精确的雷射治疗等技术进步也在市场扩张中发挥关键作用。这些创新提高了糖尿病眼部护理的准确性、安全性和可近性，从而实现更早、更有效的诊断和治疗。此外，对预防性医疗保健和早期检测的重视、对筛检项目的投资增加以及在常规医疗护理中采用糖尿病眼科疾病设备也是推动市场成长的主要因素。此外，新兴市场不断扩大的医疗基础设施以及政府为对抗糖尿病导致的失明所做的努力进一步推动了对这些设备的需求。最后，提高患者对定期眼科检查重要性的认识以及先进诊断选择的可用性正在促进市场的持续扩张，糖尿病眼科疾病设备可能会继续治疗糖尿病。

受访企业范例（共36家）

  • Aaren Scientific Inc.
  • Alcon Inc.
  • Bausch+Lomb
  • Carl Zeiss Meditec AG
  • CooperVision, Inc.
  • Essilor International SA
  • IRIDEX Corporation
  • Johnson & Johnson Innovative Medicine
  • Lumenis Be Ltd.
  • Nidek Co., Ltd.
  • Novartis AG
  • STAAR Surgical Company
  • Stryker Corporation;

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 比赛

简介目录
Product Code: MCP26707

Global Diabetic Eye Disease Devices Market to Reach US$1.6 Billion by 2030

The global market for Diabetic Eye Disease Devices estimated at US$1.0 Billion in the year 2023, is expected to reach US$1.6 Billion by 2030, growing at a CAGR of 6.2% over the analysis period 2023-2030. Vitrectomy, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$1.2 Billion by the end of the analysis period. Growth in the Laser Surgery segment is estimated at 5.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$279.5 Million While China is Forecast to Grow at 10.1% CAGR

The Diabetic Eye Disease Devices market in the U.S. is estimated at US$279.5 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$337.5 Million by the year 2030 trailing a CAGR of 10.1% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.6% and 6.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.

Global Diabetic Eye Disease Devices Market - Key Trends and Drivers Summarized

What Are Diabetic Eye Disease Devices and Why Are They Essential?

Diabetic eye disease devices are specialized medical tools and technologies designed to diagnose, monitor, and treat eye conditions associated with diabetes, such as diabetic retinopathy, diabetic macular edema, cataracts, and glaucoma. These conditions can lead to severe vision impairment or even blindness if not detected and managed promptly. Diabetic eye disease devices play a crucial role in the early detection and ongoing management of these conditions, which is vital given the progressive nature of diabetic eye diseases. The importance of these devices lies in their ability to identify early signs of retinal damage, such as microaneurysms or hemorrhages, that might not be noticeable to the patient until significant vision loss has occurred. By enabling timely interventions, these devices help prevent or slow the progression of diabetic eye diseases, thereby preserving vision and improving the quality of life for patients. As the global prevalence of diabetes continues to rise, the demand for effective and reliable diabetic eye disease devices has become more critical than ever in the fight against diabetes-related blindness.

How Are Technological Advances Enhancing Diabetic Eye Disease Devices?

Technological advancements have significantly enhanced the effectiveness, accuracy, and accessibility of diabetic eye disease devices. Modern diagnostic tools, such as optical coherence tomography (OCT) and fundus photography, provide high-resolution images of the retina, allowing for detailed examination of the eye's internal structures. These technologies have revolutionized the early detection of diabetic retinopathy and macular edema by enabling clinicians to identify minute changes in the retina that might indicate disease progression. Additionally, the integration of artificial intelligence (AI) and machine learning algorithms into these devices has further improved diagnostic accuracy and efficiency. AI-powered retinal screening tools can analyze images for signs of diabetic eye disease with a high degree of accuracy, often matching or even surpassing the performance of human experts. This technology is particularly valuable in remote or underserved areas, where access to ophthalmologists may be limited. Moreover, advancements in laser therapy devices, such as those used in panretinal photocoagulation or focal laser treatments, have improved the precision and safety of therapeutic interventions, reducing the risk of complications and enhancing patient outcomes. These technological improvements not only make diabetic eye disease devices more effective but also increase their availability and usability, helping more patients receive timely and appropriate care.

Why Are Patients and Healthcare Providers Embracing Diabetic Eye Disease Devices?

The growing adoption of diabetic eye disease devices by both patients and healthcare providers is driven by the pressing need to manage the rising burden of diabetes-related eye conditions. For patients, these devices offer a proactive approach to eye health, enabling regular monitoring and early detection of potential issues before they lead to significant vision loss. The convenience of non-invasive diagnostic tests, such as retinal imaging and OCT scans, also makes it easier for patients to undergo regular check-ups without discomfort or lengthy procedures. Additionally, the increasing awareness of the risks associated with diabetic eye disease, combined with the availability of advanced screening technologies, has encouraged more patients to seek regular eye care as part of their diabetes management plan. For healthcare providers, diabetic eye disease devices provide a reliable and efficient means of diagnosing and tracking the progression of eye conditions in diabetic patients. The ability to detect subtle retinal changes early on allows for timely interventions that can prevent severe complications, ultimately improving patient outcomes. Furthermore, the integration of AI and telemedicine solutions into these devices has expanded access to specialized care, particularly in regions where ophthalmology services are scarce, making these devices an indispensable tool in modern diabetes management.

What Factors Are Driving the Growth of the Diabetic Eye Disease Devices Market?

The growth in the diabetic eye disease devices market is driven by several key factors that reflect the increasing global prevalence of diabetes and the need for effective management of its complications. One of the primary drivers is the rising incidence of diabetes worldwide, particularly in aging populations and regions with high rates of obesity and sedentary lifestyles. As more people are diagnosed with diabetes, the demand for devices that can monitor and treat associated eye conditions has surged. Technological advancements, including the development of high-resolution imaging systems, AI-powered diagnostic tools, and more precise laser therapies, have also played a crucial role in expanding the market. These innovations have improved the accuracy, safety, and accessibility of diabetic eye care, making it possible to diagnose and treat conditions earlier and more effectively. Another significant factor driving market growth is the increasing emphasis on preventive healthcare and early detection, which has led to greater investment in screening programs and the adoption of diabetic eye disease devices in routine clinical practice. Additionally, the expansion of healthcare infrastructure in emerging markets, along with government initiatives to combat diabetes-related blindness, has further fueled the demand for these devices. Lastly, the growing awareness among patients about the importance of regular eye exams and the availability of advanced diagnostic options has contributed to the market's continued expansion, ensuring that diabetic eye disease devices will remain a critical component of diabetes care in the years to come.

Select Competitors (Total 36 Featured) -

  • Aaren Scientific Inc.
  • Alcon Inc.
  • Bausch + Lomb
  • Carl Zeiss Meditec AG
  • CooperVision, Inc.
  • Essilor International S.A.
  • IRIDEX Corporation
  • Johnson & Johnson Innovative Medicine
  • Lumenis Be Ltd.
  • Nidek Co., Ltd.
  • Novartis AG
  • STAAR Surgical Company
  • Stryker Corporation;

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Diabetic Eye Disease Devices - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Diabetes Expands Addressable Market Opportunity for Diabetic Eye Care
    • Advancements in Diagnostic Imaging Propel Growth in Diabetic Eye Disease Devices
    • Integration of AI and Machine Learning Strengthens the Business Case for Early Detection and Monitoring
    • Growing Focus on Preventive Healthcare Drives Adoption of Early Detection and Monitoring Tools
    • Innovations in Non-Invasive Testing Spur Growth in Diabetic Eye Disease Management
    • Increasing Awareness of Diabetic Retinopathy and Other Complications Generates Demand for Screening Devices
    • Expanding Healthcare Access Create New Growth Avenues for Diabetic Eye Disease Devices
    • Focus on Patient Compliance and User-Friendly Designs Sustains Growth in Home Monitoring Solutions
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Diabetic Eye Disease Devices Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Diabetic Eye Disease Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Diabetic Eye Disease Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Vitrectomy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Vitrectomy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Vitrectomy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Laser Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Laser Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Laser Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Ophthalmic Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Ophthalmic Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Ophthalmic Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Diabetic Eye Disease Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • Diabetic Eye Disease Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • Diabetic Eye Disease Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: China 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • Diabetic Eye Disease Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Diabetic Eye Disease Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for Diabetic Eye Disease Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • FRANCE
    • Diabetic Eye Disease Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: France 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • Diabetic Eye Disease Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Diabetic Eye Disease Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: UK 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Spain 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Russia 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Rest of Europe 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Diabetic Eye Disease Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Diabetic Eye Disease Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Asia-Pacific 16-Year Perspective for Diabetic Eye Disease Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Diabetic Eye Disease Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Australia 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • INDIA
    • Diabetic Eye Disease Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: India 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 113: India Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: India 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: South Korea 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Diabetic Eye Disease Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Diabetic Eye Disease Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: Latin America 16-Year Perspective for Diabetic Eye Disease Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Argentina 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Brazil 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 151: Mexico 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 157: Rest of Latin America 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Diabetic Eye Disease Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Diabetic Eye Disease Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 163: Middle East 16-Year Perspective for Diabetic Eye Disease Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 172: Iran 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 178: Israel 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 184: Saudi Arabia 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 190: UAE 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 196: Rest of Middle East 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • AFRICA
    • Diabetic Eye Disease Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Diabetic Eye Disease Devices by Surgery Type - Vitrectomy and Laser Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 202: Africa 16-Year Perspective for Diabetic Eye Disease Devices by Surgery Type - Percentage Breakdown of Value Sales for Vitrectomy and Laser Surgery for the Years 2014, 2024 & 2030
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Diabetic Eye Disease Devices by End-Use - Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Diabetic Eye Disease Devices by End-Use - Percentage Breakdown of Value Sales for Ophthalmic Clinics End-Use, Hospitals End-Use and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION